The new TurboVap® II is built on the solid foundations of reliability and performance that made it the market leader for solvent evaporation. The unit provides parallel evaporation of up to 6 samples in either 50 mL or 200 mL glassware with or without end point detection. The modern design incorporates many new customer driven features for easier use and expanded functionality. TurboVap II still utilizes the highly efficient patented gas vortex shearing technology, which is synonymous with the TurboVap brand.
Acid resistant PTFE version available.
The new TurboVap® is designed around a common chassis with interchangeable accessories, allowing users to switch quickly between configurations for a wide range of sample sizes and applications.
Biotage offers a variety of service agreements to choose from.
Our 1-Point-Support™ team is here to help you.
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people worldwide. The Group had sales of 1,092 MSEK in 2020 and our products are sold in more than 70 countries. Biotage’s share (BIOT) is listed in the Mid Cap segment on the NASDAQ Stockholm.